PROM1 and central nervous system cancer: We detected the surface expression of CD28, CD45RA, CD45RO, CCR7, and CD44 in CTL and found CD28, CD45RO, and CD44 were expressed in glioma CD133+ CSC-reactive CTL, whereas CD45RA and CCR7 were rarely expressed (Figure 9).